Terms: = Uterine cancer AND GNAQ, P50148, 2776, ENSG00000156052, G-ALPHA-q, RP11-494N1_1, GAQ AND Treatment
14085 results:
1. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
[TBL] [Abstract] [Full Text] [Related]
2. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5():CD012214. PubMed ID: 38695827
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
4. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
Huang Y; Zhou S; Su Y; Pang Z; Cai S
Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
[TBL] [Abstract] [Full Text] [Related]
5. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
[TBL] [Abstract] [Full Text] [Related]
6. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiology of uterine cancer in Sarawak, Borneo, A 20-Year Review.
Jawa D; Wong KY; Wahab MB; Azhar A; Foong EJ; Joseph EM; Pangkas J; Ooi CH
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1143-1153. PubMed ID: 38679973
[TBL] [Abstract] [Full Text] [Related]
8. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
Hosseini MS; Shafizadeh F; Bahremani MH; Farzaneh F; Ashrafganjoei T; Arab M; Talayeh M; Jafari F; Abdshah A
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2057. PubMed ID: 38662366
[TBL] [Abstract] [Full Text] [Related]
10. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
11. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
[TBL] [Abstract] [Full Text] [Related]
12. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
13. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
14. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
15. [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
Zhang J; Shao SY; Ma YJ; Qin W
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):826-830. PubMed ID: 38639596
[TBL] [Abstract] [Full Text] [Related]
16. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
17. Ultrasound-Triggered Azo Free Radicals for Cervical cancer Immunotherapy.
Wang Y; Lv B; Wang H; Ren T; Jiang Q; Qu X; Ni D; Qiu J; Hua K
ACS Nano; 2024 Apr; 18(17):11042-11057. PubMed ID: 38627898
[TBL] [Abstract] [Full Text] [Related]
18. Hypertension, Cardiovascular Risk Factors, and uterine Fibroid Diagnosis in Midlife.
Mitro SD; Wise LA; Waetjen LE; Lee C; Zaritsky E; Harlow SD; Solomon DH; Thurston RC; El Khoudary SR; Santoro N; Hedderson MM
JAMA Netw Open; 2024 Apr; 7(4):e246832. PubMed ID: 38625699
[TBL] [Abstract] [Full Text] [Related]
19. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
[TBL] [Abstract] [Full Text] [Related]
20. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract] [Full Text] [Related]
[Next]
